The Prescription for Pharma Is Revenue Growth
Despite the hullabaloo about health-care reform, investors still reward revenue growth by pharm…
Despite the hullabaloo about health-care reform, investors still reward revenue growth by pharm…
Operating leases can cut capital commitments, boost strategic flexibility, and help a company m…
Profit margins and returns on capital are important, but growth is the most important driver of…
Companies are often too conservative, setting their global investment hurdle rates too high: an…
Major capital investment decisions are typically evaluated by comparing the value of the cash t…
In the face of lackluster consumer spending growth, consumer products companies created strong …
If your company holds a lot of cash, think about doing something with it.
The industry typically delivers value to shareholders when they invest in growth – but not wh…
As companies continue to recover from the financial crisis and set their strategic plans for th…
Far too many companies stress near-term profit and cash flow rather than investing in the busin…
Apparel industry investments translate into value for shareholders only when they generate reve…
Companies can succeed by buying back shares when the price dips below its longer term trend and…
ABOUT FORTUNA ADVISORS
Our team has advised hundreds of clients on developing a new approach to creating exceptional value for stakeholders and shareholders. Our differentiated cash-based earnings approach to strategic management and capital allocation draws on years of experience as advisors and investors at Credit Suisse, Morgan Stanley, Lehman Brothers, DLJ, Stern Stewart, Marakon, Ernst & Young, and ISS.
© 2021 FORTUNA ADVISORS – ALL RIGHTS RESERVED